Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Network.
Press releases published on May 31, 2025

Snail Inc. 旗下独立品牌 Wandering Wizard 与拉丁美洲工作室 Seven Leaf Clover 达成发行合作,加速全球市场布局
加利福尼亚州卡尔弗城, May 31, 2025 (GLOBE NEWSWIRE) -- 全球领先的互动数字娱乐领域独立开发商与发行商 Snail, Inc. (Nasdaq: SNAL,以下简称 “Snail Games” 或 “公司”) 宣布,其独立游戏发行品牌 Wandering Wizard 已与阿根廷开发商 Seven Leaf Clover 达成发行合作协议,获得高强度第一人称单人射击游戏 (FPS) Rebel Engine 的发行权。 Rebel Engine 预计将于 2025 年登陆 …

Snail Inc. 旗下獨立品牌 Wandering Wizard 與拉丁美洲工作室 Seven Leaf Clover 建立發行合作夥伴關係,擴大在全球市場的影響力
加利福尼亞州卡爾弗城, May 31, 2025 (GLOBE NEWSWIRE) -- 全球領先的互動數碼娛樂獨立開發商及發行商 Snail, Inc. (Nasdaq: SNAL)(「Snail Games」或「公司」)宣布其獨立發行品牌 Wandering Wizard,與來自阿根廷的開發商 Seven Leaf Clover 建立發行合作夥伴關係,以獲取極具影響力、單人第一人稱射擊(「FPS」)遊戲 《Rebel Engine》 的發行權利。 遊戲預計將於 2025 年在 PC …

La Corporation Trans Mountain annonce ses résultats financiers pour le premier trimestre de 2025
CALGARY, Alberta, 30 mai 2025 (GLOBE NEWSWIRE) -- la Corporation Trans Mountain (la « CTM » ou la « société ») a publié ses états financiers et le rapport de la direction qui s’y rattache pour le trimestre clos le 31 mars 2025. Les résultats financiers de …

Trans Mountain Corporation Releases First Quarter 2025 Financial Results
CALGARY, Alberta, May 30, 2025 (GLOBE NEWSWIRE) -- Trans Mountain Corporation (“TMC” or “the Company”) has released its financial statements and associated management report for the three months ending March 31, 2025. The Company’s financial results are …

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
More than half of residents with tardive dyskinesia (TD) residing in long-term care (LTC) settings do not receive standard of care treatment, and one-quarter are left untreated LTC residents are often given a broader diagnosis of extrapyramidal syndrome, …

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS…
Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence rates, fewer inpatient, outpatient and emergency department (ED) visits versus second-generation daily oral options Latest Phase 3 SOLARIS data show no …

NEW WAVE ANNOUNCES Closing of Non-Brokered Private Placement of Units
VANCOUVER, BC, May 30, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (the “Company” or “New Wave”) (CSE: NWAI, FWB: 0XM0, OTCPK: TRMNF) announces, further to its news release of May 20 and May 29, 2025, that the Company has closed the previously …

Lancaster Resources Announces Closing Conditions Met for Lake Cargelligo Acquisition
VANCOUVER, British Columbia, May 30, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF0) (“Lancaster”), is pleased to announce it has received approval from the Canadian Securities Exchange to complete the acquisition of …